PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 11, 2020New England Journal of Medicine1,390 citationsOpen Access

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

View Full Paper
BCBina ChoiMCManish C. ChoudharyJRJames Regan

Key Points

Key points are not available for this paper at this time.

Abstract

SARS-CoV-2 in an Immunocompromised Host This letter describes an immunocompromised patient who had persistent infection with SARS-CoV-2 over a period of months, despite several courses of remdesivi...

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Choi et al. (2020) studied this question.

synapsesocial.com/papers/6a6132a077f983659ed08048https://doi.org/10.1056/nejmc2031364
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies2020 · 1,484 citations
  2. 2Virological assessment of hospitalized patients with COVID-20192020 · 7,240 citations
  3. 3Antiphospholipid Antibodies as a Cause of Pulmonary Capillaritis and Diffuse Alveolar Hemorrhage: A Case Series and Literature Review2005 · 114 citations
  4. 4CT suggests discharged Covid-19 patients who were retested RT-PCR positive again for SARS-CoV-2 more likely had false negative RT-PCR tests before discharging2020 · 20 citations
  5. 5Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy2020 · 152 citations